The Week Ahead

Stay informed with our weekly buzz about what’s going on in Washington, DC.

Capitol Building in Spring

Week Ahead: Springing into Waste, Fraud, and Abuse

With the Senate and House both failing to advance a War Powers Resolution, military action in Iran is heating up. The Department of Homeland Security remains shut down and now is undergoing a leadership change. The House is out this week but there is PLENTY of health policy to talk about so let’s get into it. Welcome to the Week Ahead!

The Administration

The President’s FY 2027 budget proposal is in the works and the White House is tentatively aiming to release their proposal the week of March 30. We expect the budget to highlight further ways the administration plans to address affordability and waste, fraud, and abuse in federal spending.

The March meeting of the US Preventive Services Task Force (USPSTF) has been postponed, with no confirmed rescheduled date yet. The USPSTF is responsible for making recommendations on preventive health services, such as screenings, counseling, and medications, that insurance plans must cover at no cost to patients. The task force hasn’t met since before Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., was confirmed. It seems a little ironic since the administration has been focused on keeping Americans healthy and preventing disease, no?

And resumes welcome at the Food and Drug Administration (FDA) as the head of biologics Vinay Prasad is leaving at the end of April. The FDA is also planning on reducing the number of studies that are required to demonstrate biosimilar drugs are equivalent to their brand name counterparts. With patients and industry both growing frustrated with approval pace and decisions, Commissioner Marty Makary is back in the hot seat.

The Senate

Senate Majority Leader John Thune (R-SD) has promised a speedy confirmation process for Senator Markwayne Mullin (R-OK) to replace Kristi Noem as Secretary of Homeland Security. If confirmed, Oklahoma Governor Kevin Stitt (R) will appoint an interim Senator until the November midterm elections, maintaining the Republican party’s 6-seat majority for now. Sen. Mullin’s expected departure would bring change to some key health care committees. This is because Sen. Mullin currently serves on the Senate Health, Education, Labor, and Pensions Committee and the Senate Appropriations Committee Labor-HHS subcommittee.

DHS appropriations is in the Senate’s hands, after the House passed the funding bill on March 5. Pressure to end the shutdown is mounting as Transportation Security Administration (TSA) workers receive their first $0 paycheck, which, if the past is anything to go on, will soon result in more worker call-outs and airport delays.

In the health care spotlight, Sens. Ron Wyden (D-OR), Peter Welch (D-VT), and Catherine Cortez Masto (D-NV) have been leading a Democratic prescription drug pricing working group to develop the next era of federal drug pricing policy. The group has been meeting with stakeholders to gather input and position drug affordability as a central campaign issue heading into the midterm elections.

Health Care Hearings This Week

  • March 11: Senate Aging Committee hearing on America’s drug supply chain

The House

The House Energy and Commerce Health Subcommittee is expected to hold the next hearing in its health care affordability series with the examination of hospitals and providers when House members get back after their short break this week.

Reconciliation 2.0 may be in the offing as House Republican leaders have reportedly agreed to pursue a second bite at the apple.  Will it be like the One Big, Beautiful Bill?  Our intel indicates a strong interest among House Republicans in including health care policies, especially policies aimed at addressing waste, fraud, and abuse.

There You Have It

According to Oura, the switch to Daylight Savings Time has measurable negative effects on sleep, like decreased deep sleep and more tossing and turning. Have you felt the effects? Let us know. Make it a great week!

Week Ahead: It’s Affordability, Stupid!

The attack on Iran by U.S. and Israeli forces has brought foreign affairs back to the forefront of Washington’s attention. However, concerns about affordability continue to dominate domestic headlines, as Republicans and Democrats begin to refine their messaging for the November midterm elections. Health care is a critical part of that messaging, and both sides are trying to shape the narrative. How will they do it? Let’s get into it. Welcome to the Week Ahead!

The Administration

In response to the Supreme Court decision striking down most of his 2025 tariffs, President Trump imposed a new 10% tariff for the next 150 days. While there were carve-outs for some products, such as pharmaceuticals and pharmaceutical ingredients, there are still implications for the wider health sector. The impacts are still to be felt, but concerns have been raised by groups such as the Healthcare Financial Management Association about supply chain delays  impacting the availability of personal protective equipment (PPE) and other medical equipment and supplies.

Meanwhile, March marks the start of much of the annual payment rules season, so the Office of Management and Budget (OMB) is busy. OMB has already received the Inpatient Psychiatric Facilities and Hospice Prospective Payment System proposed rules, and more are on their way, including IPPS and OPPS for FY 2027. We expect these proposed rules in March or April.

The Senate

There were fireworks during the Senate HELP Committee hearing to consider the nomination of Dr. Casey Means to be the next United States Surgeon General. Chairman Bill Cassidy (R-LA) and Sen. Lisa Murkowski (R-AK), along with many Democrats, expressed concerns about Dr. Means’ views on vaccines. While these concerns are not the same as voting against the nomination, they could make Dr. Means’ road to the office a bit bumpier. At the time of publication, Sens. Murkowski and Susan Collins (R-ME) were still undecided on the nomination. Dr. Means can only afford one Republican defection in order to avoid being rejected by the Committee.

Will HHS Sec. Robert F. Kennedy, Jr. be heading to the Hill any time soon? During an executive session on February 26, Sen. Christopher Murphy (D-CT) urged the Committee to hold future hearings on the impact of last summer’s Reconciliation bill on health care. While Chairman Cassidy did not comment on that request, he did express support for bringing Kennedy, Jr. to testify before the committee again, where the department’s changes to the Childhood Vaccination Schedule and the Advisory Committee on Immunization Practices are likely to be a hot topic.

Health Care Hearings This Week

  • March 5: Senate HELP Committee hearing on transforming health care with data and improving patient outcomes

The House

Whispers of Reconciliation 2.0 are making the rounds, and Rep. Richard Hudson, Chair of the National Republican Congressional Committee, told an audience at a BGov event that his members have begun discussing what could potentially be included. According to Rep. Hudson, any potential 2nd reconciliation package would be smaller in scope and would need alignment from all Republicans, likely making it more difficult to get off the ground.

The House Appropriations Committee is getting started on FY 2027 funding, holding a Member Day hearing for Labor-HHS on March 5. The deadline for programmatic language has been moved up several weeks (now March 20). The Labor-HHS bill will allow earmarks for the first time in 3 years, specifically for the Health Resources and Services Administration’s community project funding. This would see funds allocated to rural clinics, hospitals, and Federally Qualified Health Centers. March 20 is also the deadline for members to get these community project funding requests submitted.

Other Health Care Hearings This Week

  • March 4: House Oversight Committee hearing on fraud and misuse of federal funds in Minnesota
  • March 4: House Veterans’ Affairs Oversight Subcommittee hearing on oversight of Veterans’ health care and benefits legislation
  • March 5: House Veterans’ Affairs Health Subcommittee hearing on supporting Veterans with traumatic brain injury

There You Have It

The newly renamed Actor Awards were last night, with many worthy nominations. Were you surprised by the winners? Let us know. Make it a great week!

Week Ahead: State of (Dis)Union

Lawmakers are headed back to DC after a short break, without a clear path forward for funding the Department of Homeland Security (DHS) and foreign policy on their minds. It’s shaping up to be another big week so let’s get into it. Welcome to the Week Ahead!

The Administration

President Trump will be offering his State of the Union address on February 24. On health care, we expect the President to continue message on affordability.  And we know why – the midterms are fast approaching!

A recent KFF poll found that 66% of US adults worry about being able to afford health care for them and their family, placing health care concerns above housing, utilities, and groceries.  We expect the President to tout the launch of TrumpRx and recent efforts to reduce waste, fraud, and abuse as evidence of his success.

The Advisory Committee on Immunization Practices (ACIP) February meeting has been cancelled, following a legal challenge from the American Academy of Pediatrics over the committee members. Health and Human Services Secretary Kennedy removed all 17 ACIP members in June 2025 and selected replacements who are more skeptical about vaccines.

The Senate

While foreign policy is making the rounds on the news with the discussion of the War Powers Resolution, what is happening with health care?

Casey Means, nominated to be Surgeon General of the United States, will testify before the Senate Health, Education, Labor, and Pensions (HELP) committee on February 25. Her pick stirred up some controversy from within the Make America Health Again (MAHA) movement last year. One of Means’ most vocal critics was Laura Loomer, who raised concerns about her lack of an active medical license.

The Senate Aging Committee is holding a hearing on the regulatory process for rare diseases at the Food and Drug Administration (FDA) on February 26. This just one week after Senate HELP Chairman Bill Cassidy (R-LA) released a report on the FDA review process and reorganization. With closer looks from two Senate committees, Senate action on pushing FDA to approve treatments faster may be in the near future.

The House

Hospitals and providers will be in the spotlight in March as the House Ways and Means Committee continues looking at broad constituencies in the health care sector. As campaign season begins, both Republicans and Democrats will want to show their constituents that they are working on improving health care affordability.

In the meantime, the Health Subcommittee is holding a hearing on advancing the healthcare workforce on February 24. While not the committee that typically talks about workforce, we expect Republicans to take credit for pushing out key workforce dollars from the $50 billion Rural Health Transformation Program. Health care providers are up in arms about the concerns the Department of Education’s proposed rule on graduate and professional student loans, which would greatly limit the amount of funding for medical and nursing students. This on top of visa approvals and renewals being stalled, with the lapse in DHS funding, will certainly be hot topics.

Also, the House is buzzing with the release of the draft Farm Bill. Don’t forget the Farm Bill includes telemedicine loans and grants and rural broadband improvements.

There You Have It

The Winter Olympics have officially ended with the US walking away with 33 medals, including 2 impressive overtime gold medal wins from the men’s and women’s hockey teams. What was your favorite event? Let us know. Make it a great week!

Week Ahead: Love in the Air or ICE in the Heart

Now that most of the government funding fight is overall eyes are focused on whether Congress can figure out a path forward for funding for the Department of Homeland Security (DHS) past February 13. Will love be in the air as Valentine’s Day approaches, or will things remain at an ICE-y impasse over recent border control actions? Let’s find out. Welcome to the Week Ahead!

The Administration

The Office of Personnel Management finalized a rule on February 6 that authorizes agencies to reclassify policy-influencing employees into a new Schedule Policy/Career category. The reclassification reduces some of the job protections that career employees usually have, like the right to appeal removals, suspensions, or demotions, thereby making it easier for agencies to fire civil servants. For the Department of Health and Human Services (HHS), a whole slew of employees could fall into the “policy-influencing” category, including anyone who

  • helps write, shape, or clear policy or regulations
  • advises leadership on policy choices
  • translates statue into operational policy

Recently reported layoffs at the Advanced Research Projects Agency for Health (ARPA-H) indicate that the Trump administration is letting go non-political staff to ensure agencies are matching its priorities.

TrumpRx has launched, featuring drugs from 5 manufacturers that have agreed to most-favored-nation pricing deals. According to the White House, additional drugs will be available for purchase on the website in the coming months. However, not everyone is as optimistic as the president about the extent to which this will actually save patients money. Democratic Senators have dismissed the site, with Senate Finance Committee Ranking Member Wyden (D-OR) calling it “a glorified coupon book.” But it’s not just Democratic/progressive voices that are raising concerns. The Libertarian-leaning CATO Institute has commented that the federal government’s involvement will crowd out private innovation and incentivize cronyism. These are familiar arguments on the right, but we don’t expect many congressional Republicans to rain on the president’s parade.

The Senate

The on-again, off-again deal on extending the Advance Premium Tax Credits (APTCs) seems to be headed for a permanent breakup. Unsurprisingly, the cause of the breakup seems to be applying Hyde Amendment language to ensure subsidy funding does not go to abortion providers from the bill. Sen. Tim Kaine (D-VA) has indicated that it’s his understanding that Republicans are not willing to drop this from the bill and that Democrats need it to be dropped.

In non-APTC news, the Senate Aging Committee is scheduled to have a hearing on February 11 to examine regulatory challenges to physician practices. There are many ways this hearing could go, but policy proposals that may be brought up include ensuring appropriate Medicare physician reimbursement, reducing administrative burden on physicians, and addressing workforce shortages and burnout.

The House

While the House is busy working on a deal for DHS funding, should the health care sector care? DHS funds the Federal Emergency Management Agency, but all essential services under DHS continue like public emergencies and cybersecurity. A prolonged funding lapse could certainly affect visa processing and delay the medical supply chain. But we would argue the real reason DHS may get funded quickly is the Transportation Security Administration and all those flights lawmakers have lined up for the weekend.

House Energy and Commerce leaders are keeping true to their promise to highlight healthcare affordability by holding a Health Subcommittee hearing to examine the prescription drug supply chain on February 11. Major pharmaceutical interest groups, like PhARMA and PCMA, have been asked to testify before the committee. If the hearing goes anything like the health insurance hearings, expect a lot of finger pointing to other areas of the health sector for being the reason for increasing costs.

There You Have It

Last night’s Super Bowl was an event to watch. While it’s hard to pick just one commercial, Novartis’ commercial about blood test screenings for prostate cancer sure grabbed our attention. Talk about a tush push! Did you have a favorite commercial? Let us know. Make it a great week!

Snowy with a Side of Shutdown

While DC is still digging the city out of one of the worst winter storms of the last decade, Congress is in a storm of its own. The government entered a partial shutdown on January 31 after the Senate passed an amended minibus.  As we await House action, let’s get into it. Welcome to the Week Ahead!

The Administration

The anticipated launch of TrumpRx has gotten off to a rocky start. The platform, which will allow individuals to purchase prescription drugs at discounted rates, was supposed to launch on January 30, but is experiencing delays. While the administration has not given a reason, there has been speculation that deals with pharmaceutical companies are violating anti-kickback statute laws.

Department of Health and Human Services (HHS) Secretary Kennedy reportedly said that TrumpRx will launch “probably in the next 10 days,” indicating optimism that the holdup will be addressed quickly.

Meanwhile, changes to the Medicare Advantage (MA) program in the proposed Calendar Year 2027 MA and Part D Advance Notice are causing alarm among stakeholders.  Both AHIP and the Better Medicare Alliance hinted at possible benefits cuts should the rates be finalized as proposed.  The Association of Community Health Plans expressed concerns about the impact to safety net plans.  Even the American Hospital Association piled on, worrying that changes to the Star Ratings program could affect access to care.  With comments due February 25, proponents are scrambling to change the minds of CMS officials.

The Senate

As if the Senate heard us wondering, discussions on a potential enhanced advance premium tax credit (APTC) deal have renewed. Sen. Bernie Moreno (R-OH) reportedly shared legislative text on a compromise extension bill with 4 Democratic colleagues and is awaiting responses. But time has run out for the request by Senate Majority Leader Thune (R-SD) to have a bipartisan deal by the end of January.

Health Care Hearings This Week

  • February 3: Senate Health, Education, Labor, and Pensions (HELP) hearing on modernizing the National Institutes of Health
  • February 4: Senate Veterans’ Affairs Committee hearing on Veteran health and healing through adaptive sports

The House

Speaker Mike Johnson (R-LA-04) may have thought he had finished FY26 funding, but it is back on his to-do list.   With health care programs and health policy extenders taken care of in the Senate minibus, Johnson has to steer his caucus through a new vote strategy.

House Freedom Caucus members have previously stated that they will oppose a funding bill that does not include funding for the Department of Homeland Security. However, that was before President Trump endorsed the idea, and the Senate fell in line.  The House Rules Committee meets February 2 to set up floor debate and passage.

The House Energy and Commerce Oversight Subcommittee will hold a hearing on February 3 to examine Medicare and Medicaid fraud. The Subcommittee has recently been investigating allegations of Medicare home health and hospice payment fraud in Los Angeles County as well as Medicaid fraud in Minnesota, so this hearing will be a prime opportunity for the Subcommittee majority to highlight those actions. While the hearing is timely, remember that the Oversight Subcommittee is not responsible for writing policy related to Medicare and Medicaid fraud.  That’s up to the Health Subcommittee to determine any legislative activity in relation to the investigations.

There You Have It

We were on the edge of our seats watching the Grammys last night. Did your favorites win? Anyone you think got snubbed a la Bill Belichick? Let us know. Make it a great week!